-- MediSwitch Drug Interactions Import (Part 98/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5391, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5391, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(5391, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(23546, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(23546, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(23546, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(23546, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(23546, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(23546, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(23546, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(23546, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(23546, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(23546, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(23546, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(23546, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(23546, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(23546, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(23546, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(23546, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(23546, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(23546, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(23546, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(23546, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(23546, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(23546, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(23546, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(23546, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(23546, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(23546, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(23546, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(23546, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(23546, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(23546, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(23546, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(23546, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(23546, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(23546, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(23546, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(23546, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(23546, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(23546, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(3559, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(3559, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(3559, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(3559, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(3559, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(3559, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(3559, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution and Lidocaine w/ Epinephrine are compatible. See Compatibility section under Sodium Bicarbonate in The Handbook on Injectable Drugs by Lawrence A.', 'DailyMed'),
(3559, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(3559, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(3559, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(3559, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(3559, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(3559, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(3559, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(3559, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(3559, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(3559, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(3559, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(3559, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(3559, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(3559, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(3559, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(3559, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(3559, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(3559, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(3559, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(3559, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(3559, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(3559, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(3559, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(3559, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(3559, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(3559, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(3559, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(3559, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(3559, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(3559, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(3559, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(3559, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(5369, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(5369, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(5369, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(5369, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5369, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(5369, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(5369, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(5369, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(5369, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(5369, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(5369, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(5369, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(5369, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(5369, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(5369, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(5369, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(5369, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(5369, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(5369, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(5369, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(5369, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(5369, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(5369, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(5369, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(5369, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(5369, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(5369, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(5369, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(5369, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(5369, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(5369, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(5369, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(5369, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(5369, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(5369, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(5369, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(5369, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(5369, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(19606, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(19606, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(19606, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(19606, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(19606, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(19606, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(19606, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(19606, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(19606, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(19606, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(19606, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(19606, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(19606, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(19606, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(19606, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(19606, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(19606, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(19606, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(19606, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(19606, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(19606, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(19606, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(19606, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(19606, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(19606, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(19606, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(19606, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(19606, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(19606, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(19606, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(19606, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(19606, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(19606, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(19606, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(19606, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(19606, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(19606, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(19606, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(10908, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(10908, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(10908, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(10908, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(10908, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(10908, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(10908, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(10908, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(10908, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(10908, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(10908, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(10908, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(10908, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(10908, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(10908, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(10908, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(10908, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(10908, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(10908, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(10908, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(10908, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(10908, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(10908, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(10908, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(10908, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(10908, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(10908, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(10908, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(10908, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(10908, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(10908, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(10908, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(10908, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(10908, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(10908, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(10908, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(10908, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(10908, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(30146, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(30146, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(30146, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(30146, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(30146, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(30146, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(30146, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution and Lidocaine w/ Epinephrine are compatible. See Compatibility section under Sodium Bicarbonate in The Handbook on Injectable Drugs by Lawrence A.', 'DailyMed'),
(30146, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(30146, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(30146, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(30146, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(30146, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(30146, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(30146, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(30146, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(30146, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(30146, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(30146, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(30146, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed'),
(30146, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(30146, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(30146, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(30146, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(30146, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(30146, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(30146, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(30146, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(30146, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(30146, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(30146, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(30146, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(30146, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(30146, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(30146, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(30146, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(30146, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(30146, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(30146, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(30146, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(343, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blocker— Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents— Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'dextroamphetamine sulfate', 'N/A', 'minor', 'Both groups of agents lower blood levels and efficacy of amphetamines.Adrenergic blockers – Adrenergic blockers are inhibited by amphetamines.Alkalinizing agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Oral medication administered within one hour of the start of administration of PEG-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE may be flushed from the gastrointestinal tract and not absorbed.', 'DailyMed'),
(343, 'tetracycline hydrochloride', 'N/A', 'minor', 'Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.', 'DailyMed'),
(343, 'ranitidine hydrochloride', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(343, 'quinine sulfate', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate): Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(343, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'ranitidine', 'N/A', 'minor', 'Gefitinib: Gefitinib exposure was reduced by 44% with the coadministration of ranitidine and sodium bicarbonate (dosed to maintain gastric pH above 5.0).', 'DailyMed'),
(343, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride (140 mg/125 mg/125 mg)', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of PYLERA may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(343, 'dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(343, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents - Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'sodium bicarbonate', 'N/A', 'minor', 'Drug Interactions Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution and Lidocaine w/ Epinephrine are compatible. See Compatibility section under Sodium Bicarbonate in The Handbook on Injectable Drugs by Lawrence A.', 'DailyMed'),
(343, 'dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing Agents Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) increase absorption of amphetamines.', 'DailyMed'),
(343, 'memantine hydrochloride', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(343, 'quinidine gluconate', 'N/A', 'minor', 'Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(343, 'lithium carbonate', 'N/A', 'minor', 'The following drugs can lower serum lithium concentrations by increasing urinary lithium excretion: acetazolamide, urea, xanthine preparations and alkalinizing agents such as sodium bicarbonate.', 'DailyMed'),
(343, 'omeprazole sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.3) Omepraz', 'DailyMed'),
(343, 'omeprazole and sodium bicarbonate', 'N/A', 'major', '7 DRUG INTERACTIONS May interfere with drugs for which gastric pH can affect bioavailability (e.g., ketoconazole, ampicillin esters, iron salts, erlotinib, digoxin, and mycophenolate mofetil) (7.1) Drugs metabolized by cytochrome P450 (e.g., diazepam, warfarin, phenytoin, cyclosporine, disulfiram, benzodiazepines): Omeprazole and sodium bicarbonate can prolong their elimination. Monitor to determine the need for possible dose adjustments when taken with omeprazole and sodium bicarbonate capsules (7.2) Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time (7.2) Voriconazole: May increase plasma levels of omeprazole (7.2) Saquinavir: Omeprazole and sodium bicarbonate increases plasma levels of saquinavir (7.', 'DailyMed'),
(343, 'acetazolamide', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(343, 'bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules', 'N/A', 'minor', 'Antacids, Multivitamins, or Dairy Products The absorption of Bismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(343, 'amphetamine', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase the absorption of amphetamines.', 'DailyMed'),
(343, 'memantine hydrochloride tablets', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(343, 'cefpodoxime proxetil', 'N/A', 'minor', 'Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively.', 'DailyMed'),
(343, 'acetazolamide extended-release', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(343, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes ( 7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly ( 7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for or', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(343, 'amphetamine sulfate', 'N/A', 'minor', 'Alkalinizing agents Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored', 'N/A', 'moderate', '7 DRUG INTERACTIONS Some drugs increase risks due to fluid and electrolyte changes (7.1) Oral medication taken within 1 hour of start of each dose may not be absorbed properly (7.2) 7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities Use caution when prescribing polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution for patients who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. 7.2 Potential for Altered Drug Absorption Oral medication administered within one hour of the start of administration of polyethylene glycol 3350, sodium chloride, sodium bicarbonate', 'DailyMed'),
(343, 'omeprazole, sodium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(343, 'memantine', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(343, 'dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate', 'N/A', 'minor', 'Examples Gastrointestinal alkalinizing agents (e.g., sodium bicarbonate).', 'DailyMed'),
(343, 'omeprazole', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with omeprazole and sodium bicarbonate is contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with omeprazole and sodium bicarbonate. Nelfinavir: Avoid concomitant use with omeprazole and sodium bicarbonate.', 'DailyMed'),
(343, 'quinidine sulfate tablet', 'N/A', 'minor', 'Drug Interactions Altered Pharmacokinetics of Quinidine Drugs that alkalinize the urine (carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine.', 'DailyMed'),
(343, 'memantine hydrochloride oral', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(343, 'memantine hcl', 'N/A', 'minor', 'Carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g.', 'DailyMed'),
(343, 'bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(343, 'omeprazole/sodiium bicarbonate', 'N/A', 'contraindicated', 'Intervention: Rilpivirine-containing products: Concomitant use with Omeprazole and Sodium Bicarbonate capsules are contraindicated [see Contraindications (4)]. Atazanavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules. Nelfinavir: Avoid concomitant use with Omeprazole and Sodium Bicarbonate capsules.', 'DailyMed'),
(343, 'sodium bicarbonate injection,', 'N/A', 'minor', 'Drug Interactions Additives may be incompatible; norepinephrine and dobutamine are incompatible with sodium bicarbonate solution. The addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures.', 'DailyMed'),
(343, 'memantine hydrochloride and donepezil hydrochloride', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(343, 'quinine', 'N/A', 'minor', 'Urinary alkalizers (acetazolamide, sodium bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations.', 'DailyMed'),
(343, 'memantine and donepezil hydrochlorides', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(343, 'bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride', 'N/A', 'minor', '7.7 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(343, 'memantine and donepezil', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(343, 'acetazolamide sodium', 'N/A', 'minor', 'Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.', 'DailyMed'),
(343, 'dextroamphetamine', 'N/A', 'minor', 'Alkalinizing Agents – Gastrointestinal alkalinizing agents (sodium bicarbonate, etc.) increase absorption of amphetamines.', 'DailyMed'),
(343, 'amantadine', 'N/A', 'severe', 'Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract).', 'DailyMed'),
(343, 'bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride', 'N/A', 'minor', '7.6 Antacids, Multivitamins, or Dairy Products The absorption of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules may be reduced if administered with antacids containing aluminium, calcium, or magnesium; preparations containing iron, zinc, or sodium bicarbonate; or milk or dairy products due to the interaction between these products and tetracycline.', 'DailyMed'),
(28776, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(28776, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(28776, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22647, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22647, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22647, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22649, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22649, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22649, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(11930, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(11930, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(11930, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22650, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22650, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22650, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22648, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22648, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22648, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(14594, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(14594, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(14594, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(33198, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(33198, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(33198, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22655, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22655, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22655, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22644, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22644, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22644, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22786, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22786, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22786, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(32983, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(32983, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(32983, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22657, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22657, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22657, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22645, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22645, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22645, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22641, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22641, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22641, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(18291, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(18291, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(18291, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(8089, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(8089, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(8089, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22654, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22654, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22654, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22652, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22652, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22652, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(28778, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(28778, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(28778, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(14338, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(14338, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(14338, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22651, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22651, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22651, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(23055, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(23055, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(23055, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(23056, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(23056, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(23056, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(32982, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(32982, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(32982, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(22653, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(22653, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(22653, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(28779, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28779, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(28779, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(5019, 'folic acid', 'N/A', 'minor', 'Folic Acid Coadministration of methotrexate with folic acid or its derivatives decreases the clinical effectiveness of methotrexate in patients with neoplastic diseases.', 'DailyMed'),
(5019, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS •Oral Antibiotics: May increase hematologic and gastrointestinal toxicity. Monitor patients accordingly (7.1). •Nitrous Oxide: May increase the risk of toxicity (7.1). •NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. Monitor patients accordingly (7.1). 7.1 Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Monitor patients accordingly [see Warnings and Precautions (5.1, 5.4)]. Trimethoprim/sulfamethoxazole has been reported to increase bone marrow suppression in patients receiving methotrexate. Monit', 'DailyMed'),
(5019, 'chloramphenicol', 'N/A', 'minor', 'Oral antibiotics such as tetracycline, chloramphenicol, and nonabsorbable broad spectrum antibiotics, may decrease intestinal absorption of methotrexate or interfere with the enterohepatic circulation by inhibiting bowel flora and suppressing metabolism of the drug by bacteria.', 'DailyMed'),
(8755, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(8755, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(8755, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(8755, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(8755, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(8755, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8755, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(8755, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(8755, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8755, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(8755, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(8755, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(8755, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8755, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(8755, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(8755, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8755, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8755, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8755, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8755, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8755, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(8755, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5559, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5559, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5559, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5559, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5559, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5559, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5559, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5559, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5559, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5559, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5559, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5559, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5559, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5559, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5559, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5559, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5559, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5559, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5559, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5559, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5559, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5559, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5275, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5275, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5275, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5275, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5275, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5275, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5275, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5275, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5275, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5275, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5275, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5275, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5275, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5275, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5275, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5275, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5275, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5275, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5275, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5275, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5275, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5275, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(30135, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(30135, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(30135, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(30135, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(30135, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(30135, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30135, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(30135, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(30135, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30135, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(30135, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(30135, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(30135, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30135, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(30135, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(30135, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30135, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30135, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30135, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30135, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30135, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(30135, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(26900, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(26900, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(26900, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(26900, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(26900, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(26900, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26900, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(26900, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(26900, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26900, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(26900, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(26900, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(26900, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26900, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(26900, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(26900, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26900, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26900, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26900, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26900, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26900, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(26900, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(30480, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(30480, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(30480, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(30480, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(30480, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(30480, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30480, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(30480, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(30480, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30480, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(30480, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(30480, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(30480, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30480, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(30480, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(30480, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30480, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30480, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30480, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30480, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30480, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(30480, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(12139, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(12139, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(12139, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(12139, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(12139, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(12139, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(12139, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(12139, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(12139, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12139, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(12139, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(12139, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(12139, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(12139, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(12139, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(12139, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(12139, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(12139, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(12139, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(12139, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(12139, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(12139, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(18387, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(18387, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(18387, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(18387, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(18387, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(18387, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(18387, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(18387, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(18387, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(18387, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(18387, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(18387, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(18387, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18387, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(18387, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(18387, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18387, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18387, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(18387, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(18387, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18387, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(18387, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(29064, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(29064, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(29064, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(29064, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(29064, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(29064, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(29064, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(29064, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(29064, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(29064, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(29064, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(29064, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(29064, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(29064, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(29064, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(29064, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(29064, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(29064, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(29064, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(29064, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(29064, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(29064, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5278, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5278, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5278, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5278, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5278, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5278, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5278, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5278, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5278, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5278, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5278, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5278, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5278, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5278, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5278, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5278, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5278, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5278, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5278, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5278, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5278, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5278, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(3019, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(3019, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(3019, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(3019, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(3019, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(3019, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3019, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(3019, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(3019, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3019, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(3019, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(3019, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(3019, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3019, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(3019, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(3019, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3019, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3019, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3019, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3019, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3019, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(3019, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(8757, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(8757, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(8757, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(8757, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(8757, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(8757, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8757, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(8757, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(8757, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8757, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(8757, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(8757, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(8757, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8757, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(8757, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(8757, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8757, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8757, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8757, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8757, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8757, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(8757, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(33094, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(33094, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(33094, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(33094, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(33094, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(33094, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(33094, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(33094, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(33094, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(33094, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(33094, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(33094, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(33094, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33094, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(33094, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(33094, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33094, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33094, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33094, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(33094, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(33094, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33094, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(33094, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(13467, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(13467, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(13467, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(13467, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(13467, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(13467, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(13467, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(13467, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(13467, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(13467, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(13467, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(13467, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(13467, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13467, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(13467, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(13467, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13467, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13467, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(13467, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(13467, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13467, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(13467, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(3844, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(3844, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(3844, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(3844, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(3844, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(3844, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3844, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(3844, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(3844, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3844, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(3844, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(3844, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(3844, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3844, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(3844, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(3844, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3844, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3844, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3844, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3844, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3844, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(3844, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(16777, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(16777, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(16777, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(16777, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(16777, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(16777, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16777, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(16777, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(16777, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16777, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(16777, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(16777, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(16777, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16777, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(16777, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(16777, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16777, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16777, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16777, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16777, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16777, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16777, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(21709, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(21709, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(21709, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(21709, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(21709, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(21709, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(21709, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(21709, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(21709, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(21709, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(21709, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(21709, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(21709, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21709, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(21709, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(21709, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21709, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21709, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(21709, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(21709, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21709, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(21709, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(16246, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(16246, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(16246, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(16246, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(16246, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(16246, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16246, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(16246, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(16246, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16246, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(16246, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(16246, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(16246, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16246, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(16246, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(16246, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16246, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16246, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16246, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16246, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16246, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(16246, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(30136, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(30136, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(30136, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(30136, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(30136, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(30136, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30136, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(30136, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(30136, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(30136, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(30136, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(30136, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(30136, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30136, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(30136, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(30136, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30136, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(30136, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30136, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(30136, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(30136, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(30136, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(25681, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(25681, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(25681, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(25681, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(25681, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(25681, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(25681, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(25681, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(25681, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(25681, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(25681, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(25681, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(25681, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(25681, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(25681, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(25681, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(25681, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(25681, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(25681, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(25681, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(25681, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(25681, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(16775, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(16775, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(16775, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(16775, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(16775, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(16775, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16775, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(16775, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(16775, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16775, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(16775, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(16775, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(16775, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16775, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(16775, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(16775, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16775, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16775, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16775, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16775, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16775, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(16775, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19529, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19529, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19529, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19529, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19529, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19529, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19529, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19529, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19529, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19529, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19529, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19529, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19529, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19529, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19529, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19529, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19529, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19529, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19529, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19529, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19529, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19529, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5324, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5324, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5324, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5324, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5324, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5324, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5324, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5324, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5324, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5324, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5324, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5324, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5324, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5324, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5324, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5324, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5324, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5324, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5324, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5324, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5324, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5324, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(26901, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(26901, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(26901, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(26901, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(26901, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(26901, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26901, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(26901, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(26901, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26901, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(26901, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(26901, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(26901, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26901, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(26901, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(26901, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26901, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26901, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26901, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26901, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26901, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(26901, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(32803, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(32803, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(32803, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(32803, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(32803, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(32803, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32803, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(32803, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(32803, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32803, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(32803, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(32803, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(32803, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32803, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(32803, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(32803, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32803, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32803, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32803, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32803, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32803, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(32803, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(20033, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(20033, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(20033, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(20033, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(20033, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(20033, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(20033, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(20033, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(20033, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(20033, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(20033, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(20033, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(20033, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(20033, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(20033, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(20033, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20033, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(20033, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(20033, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(20033, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20033, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(20033, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(7203, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(7203, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(7203, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(7203, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(7203, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(7203, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(7203, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(7203, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(7203, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(7203, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(7203, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(7203, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(7203, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(7203, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(7203, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(7203, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(7203, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(7203, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(7203, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(7203, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(7203, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(7203, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5319, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5319, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5319, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5319, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5319, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5319, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5319, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5319, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5319, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5319, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5319, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5319, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5319, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5319, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5319, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5319, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5319, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5319, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5319, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5319, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5319, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5319, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(23936, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(23936, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(23936, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(23936, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(23936, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(23936, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23936, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(23936, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(23936, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23936, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(23936, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(23936, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(23936, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23936, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(23936, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(23936, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23936, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23936, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(23936, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(23936, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23936, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(23936, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(32802, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(32802, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(32802, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(32802, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(32802, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(32802, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32802, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(32802, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(32802, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32802, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(32802, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(32802, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(32802, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32802, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(32802, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(32802, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32802, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32802, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32802, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32802, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32802, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(32802, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(311, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(311, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(311, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(311, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(311, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(311, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(311, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(311, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(311, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(311, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(311, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(311, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(311, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(311, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(311, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(311, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(311, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(311, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(311, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(311, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(311, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(311, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(27436, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(27436, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(27436, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(27436, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(27436, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(27436, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27436, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(27436, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(27436, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27436, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(27436, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(27436, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(27436, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27436, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(27436, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(27436, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27436, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27436, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27436, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27436, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27436, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(27436, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19558, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19558, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19558, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(19558, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19558, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19558, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19558, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19558, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19558, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19558, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19558, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19558, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19558, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19558, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19558, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19558, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19558, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19558, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19558, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19558, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19558, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19558, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(27438, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(27438, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(27438, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(27438, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(27438, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(27438, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27438, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(27438, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(27438, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27438, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(27438, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(27438, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(27438, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27438, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(27438, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(27438, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27438, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27438, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27438, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27438, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27438, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(27438, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(24680, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(24680, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(24680, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(24680, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(24680, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(24680, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24680, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(24680, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(24680, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24680, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(24680, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(24680, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(24680, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24680, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(24680, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(24680, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24680, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24680, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24680, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24680, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24680, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(24680, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(24678, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(24678, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(24678, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(24678, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(24678, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(24678, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24678, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(24678, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(24678, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24678, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(24678, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(24678, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(24678, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24678, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(24678, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(24678, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24678, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24678, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24678, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24678, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24678, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(24678, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(20032, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(20032, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(20032, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(20032, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(20032, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(20032, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(20032, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(20032, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(20032, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(20032, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(20032, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(20032, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(20032, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(20032, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(20032, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(20032, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(20032, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(20032, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(20032, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(20032, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(20032, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(20032, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(21707, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(21707, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(21707, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(21707, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(21707, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(21707, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(21707, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(21707, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(21707, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(21707, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(21707, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(21707, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(21707, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21707, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(21707, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(21707, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21707, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(21707, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(21707, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(21707, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(21707, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(21707, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(33095, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(33095, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(33095, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(33095, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(33095, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(33095, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(33095, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(33095, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(33095, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(33095, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(33095, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(33095, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(33095, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33095, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(33095, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33095, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33095, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(33095, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(33095, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(33095, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(33095, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(33095, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(26902, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(26902, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(26902, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(26902, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(26902, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(26902, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26902, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(26902, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(26902, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(26902, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(26902, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(26902, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(26902, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26902, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(26902, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(26902, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26902, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(26902, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26902, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(26902, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(26902, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(26902, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5552, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5552, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5552, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5552, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5552, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5552, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5552, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5552, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5552, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5552, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5552, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5552, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5552, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5552, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5552, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5552, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5552, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5552, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5552, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5552, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5552, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5552, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5276, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5276, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5276, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5276, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5276, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5276, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5276, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5276, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5276, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5276, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5276, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5276, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5276, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5276, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5276, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5276, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5276, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5276, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5276, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5276, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5276, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5276, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5276, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(8759, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(8759, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(8759, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(8759, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(8759, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(8759, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8759, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(8759, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(8759, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(8759, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(8759, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(8759, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(8759, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8759, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(8759, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(8759, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8759, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(8759, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8759, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(8759, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(8759, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(8759, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19843, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19843, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19843, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19843, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19843, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19843, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19843, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19843, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19843, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19843, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19843, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19843, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19843, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19843, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19843, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19843, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19843, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19843, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19843, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19843, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19843, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19843, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19532, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19532, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19532, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19532, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19532, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19532, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19532, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19532, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19532, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19532, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19532, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19532, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19532, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19532, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19532, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19532, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19532, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19532, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19532, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19532, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19532, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19532, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(19536, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19536, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19536, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19536, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19536, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19536, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19536, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19536, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19536, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19536, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19536, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19536, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19536, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19536, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19536, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19536, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19536, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19536, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19536, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19536, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19536, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19536, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(16502, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(16502, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(16502, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(16502, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(16502, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(16502, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16502, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(16502, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(16502, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(16502, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(16502, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(16502, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(16502, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16502, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(16502, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(16502, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16502, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(16502, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16502, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(16502, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(16502, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(16502, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(13468, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(13468, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(13468, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(13468, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(13468, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(13468, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(13468, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(13468, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(13468, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(13468, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(13468, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(13468, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(13468, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13468, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(13468, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(13468, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13468, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(13468, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(13468, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(13468, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13468, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(13468, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(23469, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(23469, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(23469, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(23469, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(23469, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(23469, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23469, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(23469, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(23469, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23469, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(23469, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(23469, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(23469, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23469, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(23469, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(23469, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23469, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23469, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(23469, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(23469, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23469, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(23469, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(3017, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(3017, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(3017, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(3017, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(3017, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(3017, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3017, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(3017, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(3017, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3017, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(3017, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(3017, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(3017, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3017, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(3017, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(3017, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3017, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3017, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3017, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3017, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3017, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(3017, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19537, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19537, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19537, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19537, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19537, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19537, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19537, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19537, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19537, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19537, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19537, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19537, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19537, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19537, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19537, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19537, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19537, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19537, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19537, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19537, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19537, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19537, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(3024, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(3024, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(3024, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(3024, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(3024, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(3024, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3024, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(3024, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(3024, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3024, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(3024, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(3024, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(3024, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3024, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3024, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(3024, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(3024, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3024, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3024, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3024, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3024, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3024, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(3024, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(31938, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(31938, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(31938, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(31938, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(31938, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(31938, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(31938, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(31938, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(31938, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(31938, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(31938, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(31938, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(31938, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31938, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(31938, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(31938, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31938, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31938, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(31938, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(31938, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31938, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(31938, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19531, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19531, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19531, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19531, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19531, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19531, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19531, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19531, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19531, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19531, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19531, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19531, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19531, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19531, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19531, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19531, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19531, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19531, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19531, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19531, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19531, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19531, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(31887, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(31887, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(31887, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(31887, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(31887, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(31887, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(31887, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(31887, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(31887, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(31887, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(31887, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(31887, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(31887, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31887, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(31887, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(31887, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31887, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31887, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(31887, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(31887, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(31887, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(31887, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(31887, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(24679, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(24679, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(24679, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(24679, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(24679, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(24679, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24679, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(24679, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(24679, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(24679, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(24679, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(24679, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(24679, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24679, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(24679, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(24679, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24679, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(24679, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24679, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(24679, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(24679, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(24679, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(148, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(148, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(148, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(148, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(148, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(148, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(148, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(148, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(148, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(148, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(148, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(148, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(148, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(148, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(148, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(148, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(148, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(148, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(148, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(148, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(148, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(148, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(23467, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(23467, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(23467, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(23467, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(23467, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(23467, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23467, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(23467, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(23467, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(23467, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(23467, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(23467, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(23467, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23467, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(23467, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(23467, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23467, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(23467, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(23467, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(23467, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(23467, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(23467, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(23467, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5558, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5558, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5558, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5558, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5558, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5558, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5558, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5558, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5558, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5558, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5558, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5558, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5558, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5558, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5558, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5558, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5558, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5558, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5558, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5558, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5558, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5558, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5277, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5277, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5277, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5277, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5277, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5277, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5277, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5277, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5277, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5277, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5277, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5277, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5277, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5277, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5277, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5277, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5277, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5277, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5277, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5277, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5277, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5277, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(18386, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(18386, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(18386, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(18386, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(18386, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(18386, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(18386, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(18386, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(18386, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(18386, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(18386, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(18386, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(18386, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18386, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(18386, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(18386, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18386, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(18386, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(18386, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(18386, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18386, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(18386, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(3021, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(3021, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(3021, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(3021, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3021, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(3021, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3021, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(3021, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(3021, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(3021, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(3021, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(3021, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(3021, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3021, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(3021, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(3021, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3021, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(3021, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3021, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(3021, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(3021, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(3021, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(5320, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(5320, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(5320, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(5320, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(5320, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(5320, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5320, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(5320, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(5320, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(5320, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(5320, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(5320, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(5320, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5320, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(5320, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(5320, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5320, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(5320, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5320, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(5320, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(5320, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(5320, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(32801, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(32801, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(32801, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(32801, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(32801, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(32801, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32801, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(32801, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(32801, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(32801, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(32801, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(32801, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(32801, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32801, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(32801, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(32801, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32801, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(32801, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32801, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(32801, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(32801, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(32801, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(27437, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(27437, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(27437, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(27437, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(27437, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(27437, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27437, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(27437, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(27437, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(27437, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(27437, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27437, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(27437, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27437, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(27437, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(27437, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27437, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(27437, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27437, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(27437, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(27437, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(27437, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(19533, 'gabapentin', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day).Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy. Phenytoin In a single (400 mg) and multiple dos', 'DailyMed'),
(19533, 'levetiracetam', 'N/A', 'minor', 'Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.', 'DailyMed'),
(19533, 'gabapentin, .gamma.-aminobutyric acid', 'N/A', 'major', 'Drug Interactions In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations. No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 µg/mL (approximately 15 times the Cmax at 3600 mg/day). Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.', 'DailyMed'),
(19533, 'salicylic acid', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(19533, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7 DRUG INTERACTIONS Morphine increases gabapentin concentrations; dose adjustment may be needed ( 5.4, 7.2) 7.1 Other Antiepileptic Drugs Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs [see Clinical Pharmacology (12.3)]. 7.2 Opioids Hydrocodone Coadministration of gabapentin with hydrocodone decreases hydrocodone exposure [see Clinical Pharmacology (12.3)]. The potential for alteration in hydrocodone exposure and effect should be considered when gabapentin is started or discontinued in a patient taking hydrocodone.', 'DailyMed'),
(19533, 'tiagabine hydrochloride', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19533, 'pregabalin', 'N/A', 'minor', 'No pharmacokinetic interactions were observed between pregabalin and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid.', 'DailyMed'),
(19533, 'ramelteon', 'N/A', 'minor', 'Interaction studies of concomitant administration of ramelteon tablets with fluoxetine (CYP2D6 inhibitor), omeprazole (CYP1A2 inducer/CYP2C19 inhibitor), theophylline (CYP1A2 substrate), dextromethorphan (CYP2D6 substrate), sertraline, venlafaxine, escitalopram, gabapentin, and zolpidem did not produce clinically meaningful changes in either peak or total exposures to ramelteon or the M-II metabolite. Concomitant administration of ramelteon tablets with omeprazole (CYP2C19 substrate), dextromethorphan (CYP2D6 substrate), midazolam (CYP3A4 substrate), theophylline (CYP1A2 substrate), digoxin (p-glycoprotein substrate), warfarin (CYP2C9 [S]/CYP1A2 [R] substrate), venlafaxine, fluvoxamine, donepezil, doxepin, sertraline, escitalopram, and gabapentin did not produce clinically meaningful chang', 'DailyMed'),
(19533, 'tiagabine', 'N/A', 'minor', 'Carbamazepine, phenytoin, primidone, and phenobarbital are generally classified as enzyme inducers; valproate and gabapentin are not.', 'DailyMed'),
(19533, 'lacosamide', 'N/A', 'minor', 'The placebo-controlled clinical studies in patients with partial-onset seizures showed that steady-state plasma concentrations of levetiracetam, carbamazepine, carbamazepine epoxide, lamotrigine, topiramate, oxcarbazepine monohydroxy derivative (MHD), phenytoin, valproic acid, phenobarbital, gabapentin, clonazepam, and zonisamide were not affected by concomitant intake of lacosamide at any dose.', 'DailyMed'),
(19533, 'fingolimod', 'N/A', 'minor', 'In addition, the following commonly coprescribed substances had no clinically relevant effect (< 20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids.', 'DailyMed'),
(19533, 'gabapentin enacarbil', 'N/A', 'minor', '7 DRUG INTERACTIONS Gabapentin enacarbil is released faster from HORIZANT Extended-Release tablets in the presence of alcohol.', 'DailyMed'),
(19533, 'hydrocodone bitartrate and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19533, 'oxycodone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'fentanyl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'tramadol hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids other opioids, and alcohol.', 'DailyMed'),
(19533, 'buprenorphine and naloxone', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids Inhibitors of CYP3A4 Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inhibitors can increase the plasma concentration of buprenorphine, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of buprenorphine and naloxone sublingual tablets are achieved.', 'DailyMed'),
(19533, 'meperidine hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'morphine sulfate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'levorphanol tartrate', 'N/A', 'minor', 'Drug Interactions Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines, and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19533, 'oxymorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'oxycodone and acetaminophen', 'N/A', 'minor', 'Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants such as benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids,other opioids, alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.', 'DailyMed'),
(19533, 'butorphanol tartrate', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'hydromorphone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'methadone hydrochloride', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'buprenorphine', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19533, 'buprenorphine hydrochloride and naloxone hydrochloride dihydrate', 'N/A', 'minor', 'Examples: Alcohol, non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, and other opioids.', 'DailyMed'),
(19533, 'tramadol hydrochloride and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'tramadol hcl and acetaminophen', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(19533, 'buprenorphine hydrochloride', 'N/A', 'minor', 'Examples: Alcohol, benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids.', 'DailyMed'),
(19533, 'buprenorphine hcl', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.', 'DailyMed'),
(6442, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(33444, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(8601, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(3127, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(24753, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(30118, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(16879, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(16883, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(30117, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(4511, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(23296, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(4512, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(3763, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(23295, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(25415, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(8997, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(28527, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(8600, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(28528, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(15951, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(23297, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(4521, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(20646, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(24754, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(11642, 'drug_class', 'N/A', 'minor', 'Drug Interactions Other Antihypertensives Indapamide may add to or potentiate the action of other antihypertensive drugs. In limited controlled trials that compared the effect of indapamide combined with other antihypertensive drugs with the effect of the other drugs administered alone, there was no notable change in the nature or frequency of adverse reactions associated with the combined therapy. Lithium See WARNINGS. Post-Sympathectomy Patient The antihypertensive effect of the drug may be enhanced in the post-sympathectomized patient. Norepinephrine Indapamide, like the thiazides, may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.', 'DailyMed'),
(32072, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32072, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(21314, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(21314, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(17570, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(17570, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27858, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27858, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16293, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16293, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10348, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(10348, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27859, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27859, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(8527, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(8527, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(4214, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(4214, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(17573, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(17573, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32131, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32131, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(2543, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(2543, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31450, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(31450, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(662, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(662, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(24643, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(24643, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32120, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32120, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27462, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27462, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(31449, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(31449, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16292, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16292, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16351, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16351, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(4341, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(4341, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(18516, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(18516, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(829, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(829, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32223, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32223, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(31907, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(31907, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(2542, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(2542, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29529, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(29529, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(18515, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(18515, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(4342, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(4342, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27857, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27857, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27855, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27855, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(17574, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(17574, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(1898, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(1898, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16352, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16352, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(30311, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(30311, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10599, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(10599, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16350, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16350, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(6197, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(6197, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(16349, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(16349, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(5474, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(5474, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32806, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32806, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27860, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27860, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27463, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27463, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(18519, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(18519, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(27111, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(27111, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32185, 'doxazosin', 'N/A', 'moderate', 'Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin or tamsulosin [see Warnings and Precautions (5.6), Dosage and Administration (2.4) and Clinical Pharmacology (12.2)].', 'DailyMed'),
(32185, 'amlodipine', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(20689, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25319, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(23784, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22187, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(19099, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7730, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20686, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(13409, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22547, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25318, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25306, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22403, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22284, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(23785, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22189, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(6607, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(4918, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(19760, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20690, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(6360, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(4887, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(27056, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(2433, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25106, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(23783, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17776, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22282, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25316, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20688, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(6127, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(4921, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22640, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3786, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7877, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15545, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(1764, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25321, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(45, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22545, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7729, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(9652, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(19102, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15540, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(31908, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(1768, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(23117, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(33441, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(4886, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17062, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17778, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7879, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(13132, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(8511, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22188, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15542, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(6368, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(24701, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(27389, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20687, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22404, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7726, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17063, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15549, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17064, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(9813, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20682, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25317, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(1767, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(17780, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(2428, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20681, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20685, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(2431, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7746, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(2991, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15539, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(44, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(21200, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15547, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22471, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(431, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(22286, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(19070, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20680, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(16181, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(797, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(429, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(3791, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(6367, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25314, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15548, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(432, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(7724, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(15546, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25315, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(20683, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(4920, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(29650, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(27044, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(24702, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(18832, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(25313, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(27388, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(23915, 'drug_class', 'N/A', 'severe', 'Drug Interactions ACE-Inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. Th', 'DailyMed'),
(26059, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26058, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(29402, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(12339, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26055, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(12330, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26052, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26056, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(29406, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(24547, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(29400, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26057, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(20361, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(29391, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26061, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(24546, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(20363, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26053, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26067, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26068, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(29407, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(11915, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(26060, 'drug_class', 'N/A', 'moderate', 'Drug Interactions Ribavirin has been shown in vitro to inhibit phosphorylation of zidovudine and stavudine which could lead to decreased antiretroviral activity. Exposure to didanosine or its active metabolite (dideoxyadenosine 5’-triphosphate) is increased when didanosine is coadministered with ribavirin, which could cause or worsen clinical toxicities (see PRECAUTIONS: Drug Interactions ).', 'DailyMed'),
(28797, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28800, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28804, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28802, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28798, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28801, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28805, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28799, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(28803, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Moderate CYP2C8 inhibitors (e.g., clopidogrel, deferasirox and teriflunomide) increase exposure to the active metabolite of UPTRAVI. Reduce the dosing of UPTRAVI to once daily ( 2.6, 7.1, 12.3). CYP2C8 inducers (e.g., rifampin) decrease exposure to the active metabolite. Increase up to twice the dose of UPTRAVI ( 7.2, 12.3) 7.1 CYP2C8 Inhibitors Concomitant administration with gemfibrozil, a strong inhibitor of CYP2C8, doubled the exposure to selexipag and increased exposure to the active metabolite by approximately 11-fold. Concomitant administration of UPTRAVI with strong inhibitors of CYP2C8 (e.g., gemfibrozil) is contraindicated [see Contraindications (4) and Clinical Pharmacology (12.3)] . Concomitant administration of UPTRAVI tablets with clopidogrel, a moderate i', 'DailyMed'),
(11073, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(14146, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(11072, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(20022, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(28077, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(11313, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(7196, 'drug_class', 'N/A', 'minor', 'Drug interactions Oxyphenbutazone Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone. Insulin In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements. Corticosteroids Concurrent administration of testosterone with ACTH or corticosteroids may enhance edema formation and should be administered cautiously, particularly in patients with cardiac or hepatic disease.', 'DailyMed'),
(5244, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(5244, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(21554, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(21554, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7126, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7126, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19494, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19494, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7069, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7069, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(23970, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(23970, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(17728, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(17728, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7131, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7131, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7125, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7125, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(3765, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(3765, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(27410, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(27410, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7129, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7129, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19433, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19433, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(27409, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(27409, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19492, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19492, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19671, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19671, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19434, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19434, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19488, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19488, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(5242, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(5242, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(5243, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(5243, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(21552, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(21552, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(23969, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(23969, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19490, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19490, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19487, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19487, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7071, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7071, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(21629, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(21629, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(9131, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(9131, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7132, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7132, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(26722, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(26722, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(10159, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(10159, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19489, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19489, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(7134, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(7134, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(19436, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(19436, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(10160, 'salicylic acid', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(10160, 'drug_class', 'N/A', 'severe', '7 DRUG INTERACTIONS Aminoglycoside antibiotics: Increased potential ototoxicity of the antibiotics. Avoid combination (7.1) Ethacrynic acid: Risk of ototoxicity. Avoid combination (7.1) Salicylates: Risk of salicylate toxicity (7.1) Cisplatin and nephrotoxic drugs: Risk of ototoxicity and nephrotoxicity (7.1) Lithium: Risk of lithium toxicity (7.1) Renin-angiotensin inhibitors: Increased risk of hypotension and renal failure. (7.1) Adrenergic blocking drugs: Risk of potentiation (7.1) Drugs undergoing renal tubular secretion: Risk of toxicity potentiation (7.1) 7.1 Effects of Furosemide on Other Drugs Drug/Substance Class or Name Drug Interaction Effect Recommendations Aminoglycoside antibiotics Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the', 'DailyMed'),
(29983, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29971, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(31882, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(31777, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(6467, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(25655, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1397, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(18161, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29764, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(19769, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(10814, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14795, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29967, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12894, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(32478, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(18474, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(7590, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12889, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(33927, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1213, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14813, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12891, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12886, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1185, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(18475, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29981, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29968, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(25654, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12883, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14819, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12893, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29970, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(16985, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(27836, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(11939, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(31653, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29743, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(25951, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12701, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12690, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(3699, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12704, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(15990, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12892, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14818, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12705, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(7640, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1217, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(32037, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29761, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1206, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(32475, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14794, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(13059, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(28789, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14784, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(13060, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14796, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12890, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(32477, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29980, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(3403, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(28788, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(13061, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1205, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12895, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1219, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(8700, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(33262, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(3402, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1207, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(18473, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1204, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(28787, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29850, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14834, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1208, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(12702, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(17238, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14817, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29965, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(29973, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1214, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1201, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(19768, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1216, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1203, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(14885, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(1218, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Warfarin: Use with azithromycin may increase coagulation times; monitor prothrombin time (7) Warfarin Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.', 'DailyMed'),
(25267, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(25267, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25267, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25272, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(25272, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25272, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25273, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(25273, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25273, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(14975, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(14975, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(14975, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(31557, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(31557, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(31557, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(31558, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(31558, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(31558, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(14976, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(14976, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(14976, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(29100, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(29100, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(29100, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25268, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(25268, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(25268, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(29101, 'venlafaxine', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS 7.1 Monoamine Oxidase Inhibitors (MAOI) Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine. Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration (2.6), Contraindications (4) and Warnings and Precautions (5.2)].', 'DailyMed'),
(29101, 'tramadol', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(29101, 'iron', 'N/A', 'minor', 'Examples Other SNRIs, SSRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St.', 'DailyMed'),
(22925, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(3537, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(17422, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(21151, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(17425, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(17423, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(17421, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(3556, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(4256, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(5109, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(17420, 'drug_class', 'N/A', 'severe', 'Clinically Significant Drug Interactions:The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.', 'DailyMed'),
(33832, 'metformin hydrochloride', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration.', 'DailyMed'),
(33832, 'metformin', 'N/A', 'major', 'Drug Interactions (clinical evaluation of drug interactions conducted with metformin) Glyburide: In a single-dose interaction study in type 2 diabetes subjects, co-administration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration. Furosemide i', 'DailyMed'),
(33832, 'chloramphenicol', 'N/A', 'minor', 'When such drugs are administered to a patient receiving metformin, the patient should be closely observed to maintain adequate glycemic control.In healthy volunteers, the pharmacokinetics of metformin and propranolol and metformin and ibuprofen were not affected when co-administered in single-dose interaction studies.Metformin is negligibly bound to plasma proteins and is, therefore, less likely to interact with highly protein-bound drugs such as salicylates, sulfonamides, chloramphenicol, and probenecid, as compared to the sulfonylureas, which are extensively bound to serum proteins.', 'DailyMed'),
(33832, 'glyburide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33832, 'glipizide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glipizide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving glipizide and metformin hydrochloride tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving glipizide and metformin hydrochloride tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33832, 'glyburide and metformin', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(33832, 'metformin hydrochloride, tyrosine', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP and Oral Sulfonylurea Therapy in Adult Patients).', 'DailyMed'),
(33832, 'pioglitazone hydrochloride and metformin hydrochloride', 'N/A', 'moderate', 'Metformin hydrochloride See PRECAUTIONS, Drug Interactions, Metformin hydrochloride', 'DailyMed'),
(33832, 'metformin hydrochloride er', 'N/A', 'moderate', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP or Metformin Hydrochloride Extended-release Tablets, USP and Oral Sulfonylurea Therapy). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of metformin hydrochloride tablets, USP or metformin hydrochloride extended-release tablets, USP and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system. When such drugs are administered to a patient receiving metformin hydr', 'DailyMed'),
(33832, 'glyburide-metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33832, 'pioglitazone and metformin', 'N/A', 'moderate', 'Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of pioglitazone and metformin hydrochloride and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system [see CLINICAL PHARMACOLOGY (12.3)]. When such drugs are administered to a patient receiving pioglitazone and metformin hydrochloride, the patient should be closely observed for loss of blood glucose control.', 'DailyMed'),
(33832, 'metformin hcl', 'N/A', 'moderate', 'DRUG INTERACTIONS (Clinical Evaluation of Drug Interactions Conducted with Metformin Hydrochloride Tablets USP) Glyburide—In a single-dose interaction study in type 2 diabetes patients, coadministration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets USP and Oral Sulfonylurea Therapy in Adult Patients). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of Metformin Hydrochloride Tablets USP and/or t', 'DailyMed'),
(33832, 'glipizide and metformin hcl', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(33832, 'metformin hydrochloride extended-release tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(33832, 'drug_class', 'N/A', 'severe', 'DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor''s approval. Many drugs can affect your blood sugar levels, making it more difficult to control your blood sugar. Before you start, stop, or change any medication, talk with your doctor or pharmacist about how the medication may affect your blood sugar. Check your blood sugar levels regularly as directed by your doctor. Tell your doctor about the results and of any symptoms of high ', 'DailyMed'),
(33832, 'alogliptin and metformin hydrochloride', 'N/A', 'minor', '(7) Metformin Hydrochloride Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS may increase the risk of lactic acidosis. Intervention: Warn patients against excessive alcohol intake while receiving ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS.', 'DailyMed'),
(33832, 'sitagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Table 4 presents clinically significant drug interactions with sitagliptin and metformin hydrochloride extended-release tablets: Table 4 Clinically Significant Drug Interactions with Sitagliptin and Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with sitagliptin and metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis. Intervention: Consider the benefits and risks of concomitant use with sitagliptin and metformin hydrochloride extended-release tablets.', 'DailyMed'),
(33832, 'metformin hydrochloride tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(33832, 'saxagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptinwhen coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration ( 2.3 ) and Clinical Pharmacology ( 12.3 )].', 'DailyMed'),
(33832, 'saxagliptin and metformin', 'N/A', 'major', '7 DRUG INTERACTIONS • Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptin when coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration (2.3) and Clinical Pharmacology (12.3) ].', 'DailyMed'),
(33832, 'metformin hydrochloride extended-release', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(33832, 'pioglitazole and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(33832, 'pioglitazone hcl and metformin hcl', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride tablets dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets (45 mg of pioglitazone and 2,550 mg of me', 'DailyMed'),
(33832, 'metformin er  500 mg', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(33832, 'metformin hydrochloride tablet', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride tablets may increase the risk for lactic acidosis. Drugs that Reduce metformin hydrochloride tablet Clearance Clinical Impact: Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis ', 'DailyMed'),
(33832, 'pioglitazone and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(17601, 'metformin hydrochloride', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration.', 'DailyMed'),
(17601, 'metformin', 'N/A', 'major', 'Drug Interactions (clinical evaluation of drug interactions conducted with metformin) Glyburide: In a single-dose interaction study in type 2 diabetes subjects, co-administration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration. Furosemide i', 'DailyMed'),
(17601, 'chloramphenicol', 'N/A', 'minor', 'When such drugs are administered to a patient receiving metformin, the patient should be closely observed to maintain adequate glycemic control.In healthy volunteers, the pharmacokinetics of metformin and propranolol and metformin and ibuprofen were not affected when co-administered in single-dose interaction studies.Metformin is negligibly bound to plasma proteins and is, therefore, less likely to interact with highly protein-bound drugs such as salicylates, sulfonamides, chloramphenicol, and probenecid, as compared to the sulfonylureas, which are extensively bound to serum proteins.', 'DailyMed'),
(17601, 'glyburide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(17601, 'glipizide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glipizide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving glipizide and metformin hydrochloride tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving glipizide and metformin hydrochloride tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(17601, 'glyburide and metformin', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(17601, 'metformin hydrochloride, tyrosine', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP and Oral Sulfonylurea Therapy in Adult Patients).', 'DailyMed'),
(17601, 'pioglitazone hydrochloride and metformin hydrochloride', 'N/A', 'moderate', 'Metformin hydrochloride See PRECAUTIONS, Drug Interactions, Metformin hydrochloride', 'DailyMed'),
(17601, 'metformin hydrochloride er', 'N/A', 'moderate', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP or Metformin Hydrochloride Extended-release Tablets, USP and Oral Sulfonylurea Therapy). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of metformin hydrochloride tablets, USP or metformin hydrochloride extended-release tablets, USP and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system. When such drugs are administered to a patient receiving metformin hydr', 'DailyMed'),
(17601, 'glyburide-metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(17601, 'pioglitazone and metformin', 'N/A', 'moderate', 'Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of pioglitazone and metformin hydrochloride and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system [see CLINICAL PHARMACOLOGY (12.3)]. When such drugs are administered to a patient receiving pioglitazone and metformin hydrochloride, the patient should be closely observed for loss of blood glucose control.', 'DailyMed'),
(17601, 'metformin hcl', 'N/A', 'moderate', 'DRUG INTERACTIONS (Clinical Evaluation of Drug Interactions Conducted with Metformin Hydrochloride Tablets USP) Glyburide—In a single-dose interaction study in type 2 diabetes patients, coadministration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets USP and Oral Sulfonylurea Therapy in Adult Patients). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of Metformin Hydrochloride Tablets USP and/or t', 'DailyMed'),
(17601, 'glipizide and metformin hcl', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(17601, 'metformin hydrochloride extended-release tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(17601, 'drug_class', 'N/A', 'severe', 'DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor''s approval. Many drugs can affect your blood sugar levels, making it more difficult to control your blood sugar. Before you start, stop, or change any medication, talk with your doctor or pharmacist about how the medication may affect your blood sugar. Check your blood sugar levels regularly as directed by your doctor. Tell your doctor about the results and of any symptoms of high ', 'DailyMed'),
(17601, 'alogliptin and metformin hydrochloride', 'N/A', 'minor', '(7) Metformin Hydrochloride Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS may increase the risk of lactic acidosis. Intervention: Warn patients against excessive alcohol intake while receiving ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS.', 'DailyMed'),
(17601, 'sitagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Table 4 presents clinically significant drug interactions with sitagliptin and metformin hydrochloride extended-release tablets: Table 4 Clinically Significant Drug Interactions with Sitagliptin and Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with sitagliptin and metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis. Intervention: Consider the benefits and risks of concomitant use with sitagliptin and metformin hydrochloride extended-release tablets.', 'DailyMed'),
(17601, 'metformin hydrochloride tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(17601, 'saxagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptinwhen coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration ( 2.3 ) and Clinical Pharmacology ( 12.3 )].', 'DailyMed'),
(17601, 'saxagliptin and metformin', 'N/A', 'major', '7 DRUG INTERACTIONS • Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptin when coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration (2.3) and Clinical Pharmacology (12.3) ].', 'DailyMed'),
(17601, 'metformin hydrochloride extended-release', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(17601, 'pioglitazole and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(17601, 'pioglitazone hcl and metformin hcl', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride tablets dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets (45 mg of pioglitazone and 2,550 mg of me', 'DailyMed'),
(17601, 'metformin er  500 mg', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(17601, 'metformin hydrochloride tablet', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride tablets may increase the risk for lactic acidosis. Drugs that Reduce metformin hydrochloride tablet Clearance Clinical Impact: Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis ', 'DailyMed'),
(17601, 'pioglitazone and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(31582, 'metformin hydrochloride', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration.', 'DailyMed'),
(31582, 'metformin', 'N/A', 'major', 'Drug Interactions (clinical evaluation of drug interactions conducted with metformin) Glyburide: In a single-dose interaction study in type 2 diabetes subjects, co-administration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration. Furosemide i', 'DailyMed'),
(31582, 'chloramphenicol', 'N/A', 'minor', 'When such drugs are administered to a patient receiving metformin, the patient should be closely observed to maintain adequate glycemic control.In healthy volunteers, the pharmacokinetics of metformin and propranolol and metformin and ibuprofen were not affected when co-administered in single-dose interaction studies.Metformin is negligibly bound to plasma proteins and is, therefore, less likely to interact with highly protein-bound drugs such as salicylates, sulfonamides, chloramphenicol, and probenecid, as compared to the sulfonylureas, which are extensively bound to serum proteins.', 'DailyMed'),
(31582, 'glyburide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(31582, 'glipizide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glipizide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving glipizide and metformin hydrochloride tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving glipizide and metformin hydrochloride tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(31582, 'glyburide and metformin', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(31582, 'metformin hydrochloride, tyrosine', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP and Oral Sulfonylurea Therapy in Adult Patients).', 'DailyMed'),
(31582, 'pioglitazone hydrochloride and metformin hydrochloride', 'N/A', 'moderate', 'Metformin hydrochloride See PRECAUTIONS, Drug Interactions, Metformin hydrochloride', 'DailyMed'),
(31582, 'metformin hydrochloride er', 'N/A', 'moderate', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP or Metformin Hydrochloride Extended-release Tablets, USP and Oral Sulfonylurea Therapy). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of metformin hydrochloride tablets, USP or metformin hydrochloride extended-release tablets, USP and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system. When such drugs are administered to a patient receiving metformin hydr', 'DailyMed'),
(31582, 'glyburide-metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(31582, 'pioglitazone and metformin', 'N/A', 'moderate', 'Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of pioglitazone and metformin hydrochloride and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system [see CLINICAL PHARMACOLOGY (12.3)]. When such drugs are administered to a patient receiving pioglitazone and metformin hydrochloride, the patient should be closely observed for loss of blood glucose control.', 'DailyMed'),
(31582, 'metformin hcl', 'N/A', 'moderate', 'DRUG INTERACTIONS (Clinical Evaluation of Drug Interactions Conducted with Metformin Hydrochloride Tablets USP) Glyburide—In a single-dose interaction study in type 2 diabetes patients, coadministration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets USP and Oral Sulfonylurea Therapy in Adult Patients). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of Metformin Hydrochloride Tablets USP and/or t', 'DailyMed'),
(31582, 'glipizide and metformin hcl', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(31582, 'metformin hydrochloride extended-release tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(31582, 'drug_class', 'N/A', 'severe', 'DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor''s approval. Many drugs can affect your blood sugar levels, making it more difficult to control your blood sugar. Before you start, stop, or change any medication, talk with your doctor or pharmacist about how the medication may affect your blood sugar. Check your blood sugar levels regularly as directed by your doctor. Tell your doctor about the results and of any symptoms of high ', 'DailyMed'),
(31582, 'alogliptin and metformin hydrochloride', 'N/A', 'minor', '(7) Metformin Hydrochloride Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS may increase the risk of lactic acidosis. Intervention: Warn patients against excessive alcohol intake while receiving ALOGLIPTIN WITH METFORMIN HYDROCHLORIDE TABLETS.', 'DailyMed'),
(31582, 'sitagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Table 4 presents clinically significant drug interactions with sitagliptin and metformin hydrochloride extended-release tablets: Table 4 Clinically Significant Drug Interactions with Sitagliptin and Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with sitagliptin and metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis. Intervention: Consider the benefits and risks of concomitant use with sitagliptin and metformin hydrochloride extended-release tablets.', 'DailyMed'),
(31582, 'metformin hydrochloride tablets', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(31582, 'saxagliptin and metformin hydrochloride', 'N/A', 'major', '7 DRUG INTERACTIONS Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptinwhen coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration ( 2.3 ) and Clinical Pharmacology ( 12.3 )].', 'DailyMed'),
(31582, 'saxagliptin and metformin', 'N/A', 'major', '7 DRUG INTERACTIONS • Strong CYP3A4/5 inhibitors (e.g., ketoconazole): Coadministration with saxagliptin and metformin hydrochloride extended-release tablets significantly increases saxagliptin concentrations. Limit saxagliptin and metformin hydrochloride extended-release tablets dosage to 2.5 mg/1,000 mg once daily when coadministered with a strong CYP3A4/5 inhibitor. The dose of saxagliptin and metformin hydrochloride extended-release tablets should be limited to 2.5 mg of saxagliptin when coadministered with a strong CYP3A4/5 inhibitor [see Dosage and Administration (2.3) and Clinical Pharmacology (12.3) ].', 'DailyMed'),
(31582, 'metformin hydrochloride extended-release', 'N/A', 'major', '7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 2: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(31582, 'pioglitazole and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(31582, 'pioglitazone hcl and metformin hcl', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride tablets dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets (45 mg of pioglitazone and 2,550 mg of me', 'DailyMed'),
(31582, 'metformin er  500 mg', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3 presents clinically significant drug interactions with metformin hydrochloride extended-release tablets. Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis.', 'DailyMed'),
(31582, 'metformin hydrochloride tablet', 'N/A', 'major', '7 DRUG INTERACTIONS Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with metformin hydrochloride tablets may increase the risk for lactic acidosis. Drugs that Reduce metformin hydrochloride tablet Clearance Clinical Impact: Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis ', 'DailyMed'),
(31582, 'pioglitazone and metformin hydrochloride', 'N/A', 'minor', '7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors [see Dosage and Administration (2.3), Clinical Pharmacology (12.3)]. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin', 'DailyMed'),
(33195, 'metformin hydrochloride', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration.', 'DailyMed'),
(33195, 'metformin', 'N/A', 'major', 'Drug Interactions (clinical evaluation of drug interactions conducted with metformin) Glyburide: In a single-dose interaction study in type 2 diabetes subjects, co-administration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride and Oral Sulfonylurea Therapy in Adult Patients).Furosemide: A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by co-administration. Furosemide i', 'DailyMed'),
(33195, 'chloramphenicol', 'N/A', 'minor', 'When such drugs are administered to a patient receiving metformin, the patient should be closely observed to maintain adequate glycemic control.In healthy volunteers, the pharmacokinetics of metformin and propranolol and metformin and ibuprofen were not affected when co-administered in single-dose interaction studies.Metformin is negligibly bound to plasma proteins and is, therefore, less likely to interact with highly protein-bound drugs such as salicylates, sulfonamides, chloramphenicol, and probenecid, as compared to the sulfonylureas, which are extensively bound to serum proteins.', 'DailyMed'),
(33195, 'glyburide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33195, 'glipizide and metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glipizide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving glipizide and metformin hydrochloride tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving glipizide and metformin hydrochloride tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33195, 'glyburide and metformin', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed'),
(33195, 'metformin hydrochloride, tyrosine', 'N/A', 'minor', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP and Oral Sulfonylurea Therapy in Adult Patients).', 'DailyMed'),
(33195, 'pioglitazone hydrochloride and metformin hydrochloride', 'N/A', 'moderate', 'Metformin hydrochloride See PRECAUTIONS, Drug Interactions, Metformin hydrochloride', 'DailyMed'),
(33195, 'metformin hydrochloride er', 'N/A', 'moderate', 'The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets, USP or Metformin Hydrochloride Extended-release Tablets, USP and Oral Sulfonylurea Therapy). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of metformin hydrochloride tablets, USP or metformin hydrochloride extended-release tablets, USP and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system. When such drugs are administered to a patient receiving metformin hydr', 'DailyMed'),
(33195, 'glyburide-metformin hydrochloride', 'N/A', 'minor', 'Drug Interactions Glyburide and Metformin Hydrochloride Tablets Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When such drugs are administered to a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Glyburide and Metformin Hydrochloride Tablets, the patient should be observed closely for hypoglycemia.', 'DailyMed'),
(33195, 'pioglitazone and metformin', 'N/A', 'moderate', 'Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of pioglitazone and metformin hydrochloride and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system [see CLINICAL PHARMACOLOGY (12.3)]. When such drugs are administered to a patient receiving pioglitazone and metformin hydrochloride, the patient should be closely observed for loss of blood glucose control.', 'DailyMed'),
(33195, 'metformin hcl', 'N/A', 'moderate', 'DRUG INTERACTIONS (Clinical Evaluation of Drug Interactions Conducted with Metformin Hydrochloride Tablets USP) Glyburide—In a single-dose interaction study in type 2 diabetes patients, coadministration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics. The single-dose nature of this study and the lack of correlation between glyburide blood levels and pharmacodynamic effects, makes the clinical significance of this interaction uncertain (see DOSAGE AND ADMINISTRATION: Concomitant Metformin Hydrochloride Tablets USP and Oral Sulfonylurea Therapy in Adult Patients). Although such interactions remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of Metformin Hydrochloride Tablets USP and/or t', 'DailyMed'),
(33195, 'glipizide and metformin hcl', 'N/A', 'minor', 'Metformin Hydrochloride Furosemide A single-dose, metformin-furosemide drug interaction study in healthy subjects demonstrated that pharmacokinetic parameters of both compounds were affected by coadministration.', 'DailyMed');

